000 01036 a2200289 4500
005 20250518035518.0
264 0 _c20200512
008 202005s 0 0 eng d
022 _a1527-7755
024 7 _a10.1200/JCO.18.02369
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aQin, Shukui
245 0 0 _aReply to C. Kersten et al and D.A. Parikh et al.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_c06 2019
300 _a1592-1593 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aCetuximab
650 0 4 _aFluorouracil
650 0 4 _aHumans
650 0 4 _aLeucovorin
650 0 4 _aOxaliplatin
650 0 4 _aRectal Neoplasms
700 1 _aLiu, Tianshu
700 1 _aLi, Jin
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 37
_gno. 18
_gp. 1592-1593
856 4 0 _uhttps://doi.org/10.1200/JCO.18.02369
_zAvailable from publisher's website
999 _c29648905
_d29648905